These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3701167)

  • 21. [A case of recurrent breast cancer responding to long-term administration of tamoxifen].
    Yayoi E; Kobayashi T; Inaji H; Maeura Y; Mori T
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1683-6. PubMed ID: 6433801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
    Kaufmann M; Rody A
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):146-54. PubMed ID: 16621229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive implications of nucleoside metabolizing enzymes in premenopausal women with node-positive primary breast cancer who were randomly assigned to receive tamoxifen alone or tamoxifen plus tegafur-uracil as adjuvant therapy.
    Toi M; Ikeda T; Akiyama F; Kurosumi M; Tsuda H; Sakamoto G; Abe O
    Int J Oncol; 2007 Oct; 31(4):899-906. PubMed ID: 17786323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Response to rechallenged tamoxifen of metastatic breast cancer relapsed after surgical adjuvant tamoxifen treatment].
    Abe O; Nomura Y; Izuo M; Tominaga T; Koyama H; Tashiro H
    Gan To Kagaku Ryoho; 1991 Jul; 18(8):1333-6. PubMed ID: 2069403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The treatment of metastasising mammary carcinoma with drostanolone propionate (masterid) (author's transl)].
    von Lieven H; Büll U
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2043-6. PubMed ID: 4216810
    [No Abstract]   [Full Text] [Related]  

  • 26. [The efficacy of surgical resection and chemo-endocrine therapy for patients with local recurrence or axillary lymph node metastasis of breast cancer].
    Hojo S; Yoshioka S; Yoshioka A; Fujie Y; Fukunaga H; Okada Y; Ota H; Endo W; Maeura Y
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2216-8. PubMed ID: 19106575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tamoxifen therapy of metastatic breast cancer.
    Manni A
    J Lab Clin Med; 1987 Mar; 109(3):290-9. PubMed ID: 2950193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tamoxifen plus tegafur plus low-dose adriamycin in the treatment of advanced breast cancer in an outpatient basis].
    Shiba E; Koyama H; Noguchi S; Nishizawa Y; Iwanaga T; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1987 Oct; 22(9):2196-201. PubMed ID: 3128615
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of estrogen dependency of human breast cancers. II. Clinical evaluation of tamoxifen in advanced primary and recurrent breast cancer.
    Nishiki M; Yamane M; Amano K; Yasuda K; Okumichi T; Ezaki H
    Hiroshima J Med Sci; 1984 Jun; 33(2):163-6. PubMed ID: 6480380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemo-endocrine therapy of advanced breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3214-20. PubMed ID: 2973769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A combined effect of fadrozole and tamoxifen in postmenopausal patients with recurrent breast cancer: a preliminary report: Japanese Cooperative Study Group of Fadrozole and Tamoxifen].
    Tominaga T; Kimura M; Toge T; Takashima S; Nomura Y; Ohashi Y
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1709-18. PubMed ID: 11057322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A controlled study with medroxyprogesterone acetate (MPA) alone or in combination with cyclophosphamide (CPA) in the treatment of advanced or recurrent breast cancer unresponsive to other therapies. Osaka Study Group for the Treatment of Breast Cancer].
    Aikawa T; Yayoi E; Takatsuka Y; Maeura Y; Miyauchi K
    Gan To Kagaku Ryoho; 1991 May; 18(6):995-1002. PubMed ID: 1827575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.
    Kubota T; Abe O; Izuo M; Watanabe H; Enomoto K; Ohsawa N; Kuno K
    Anticancer Res; 1993; 13(6B):2361-5. PubMed ID: 8135468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of tamoxifen in the long-term treatment and prevention of breast cancer.
    Jordan VC
    Oncology (Williston Park); 1988 Sep; 2(9):19-28. PubMed ID: 3079292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy and hormone therapy of metastatic breast cancer.
    Paterson AH
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):631-3. PubMed ID: 3835708
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tamoxifen therapy in locally advanced primary and recurrent breast cancer (author's transl)].
    Wada T; Koyama H; Takahashi Y; Nishizawa Y; Iwanaga T; Aoki Y; Terasawa T
    Nihon Gan Chiryo Gakkai Shi; 1979 Aug; 14(5):819-24. PubMed ID: 501187
    [No Abstract]   [Full Text] [Related]  

  • 37. Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
    Falkson G; Gelman RS; Tormey DC; Taylor SG; Falkson HC
    Cancer Treat Rep; 1985; 69(7-8):755-60. PubMed ID: 4016786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of response to therapy in advanced breast cancer].
    Terasawa T
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2235-42. PubMed ID: 3717968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
    Illiger HJ
    Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemo-endocrine therapy with high dose medroxyprogesterone acetate for recurrent or advanced breast cancer].
    Maeda T; Kubo Y; Sasajima T; Ikeda K; Hirata S; Yamazaki K; Nakajima S
    Gan To Kagaku Ryoho; 1993 Nov; 20(14):2165-9. PubMed ID: 8239681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.